GLUCOTRACK INC (GCTK)
NASDAQHealth CareMedical - DevicesSnapshot 2026-11-04
$0.38-5.00%
Close 2026-11-05 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-11-04
QuarterlyIQ Insights · GCTK
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | — | — | — | — | — | — | — | 0.2 | 0.0 | 0.6 | 0.6 | 0.1 | 0.1 | — | — | — |
| Total Revenues | — | — | — | — | — | — | — | — | — | 0.6 | 0.6 | 0.1 | 0.1 | — | — | — |
| Operating Expenses & Income | ||||||||||||||||
| Selling, General & Admin | — | — | — | — | — | 0.1 | 0.4 | — | — | 1.5 | 1.1 | 1.1 | 0.2 | — | — | — |
| R&D Expenses | 8.9 | 9.8 | 9.5 | 4.7 | 2.0 | 1.8 | 1.5 | 1.6 | 3.0 | 3.2 | 2.9 | 2.3 | 1.8 | 2.0 | 1.9 | 1.8 |
| Operating Income | (15.4) | (16.1) | (14.5) | (7.1) | (4.4) | (4.0) | (3.1) | 3.5 | (6.5) | 10.6 | (5.7) | (4.7) | (3.6) | (3.0) | (2.8) | (2.3) |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | — | 0.0 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Non-Operating Income / Expenses | — | (3.3) | — | — | — | — | — | (0.0) | (0.2) | — | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | — | — | — | — | — | — | (2.7) | (3.5) | (6.7) | (10.3) | (5.4) | (5.8) | 3.0 | (9.8) | (2.8) | — |
| Net Income | ||||||||||||||||
| Net Income | (15.9) | (19.4) | (22.6) | (7.1) | (4.4) | (4.1) | (2.7) | 3.5 | (6.7) | 10.3 | (5.4) | (5.8) | 3.0 | (9.8) | (2.8) | (2.4) |
| Per Share | ||||||||||||||||
| Basic EPS | (3.18) | 31.22 | 68.44 | 34.18 | 0.29 | 0.26 | (0.02) | (0.02) | (4.74) | (1.87) | (1.08) | (1.15) | 0.37 | — | — | — |
| Diluted EPS | (3.18) | 31.22 | 68.44 | 34.18 | 0.29 | 0.26 | 0.19 | (0.02) | (4.74) | (1.87) | (1.08) | (1.15) | 0.37 | — | — | — |
| Basic Weighted Avg Shares | 5.0 | 0.6 | 0.3 | 0.2 | 15.5 | 15.5 | 196.0 | 154.9 | 8.4 | 6.3 | 5.8 | 5.5 | 5.3 | — | — | — |
| Diluted Weighted Avg Shares | 5.0 | 0.6 | 0.3 | 0.2 | 15.5 | — | 196.0 | 154.9 | 8.4 | 6.3 | 5.8 | 5.5 | 5.3 | — | — | — |
| Supplemental | ||||||||||||||||
| EBITDA | — | — | — | — | — | (4.0) | (3.1) | — | — | — | — | — | — | — | (2.7) | — |
| EBIT | (15.4) | (16.1) | (14.5) | (7.1) | (4.4) | (4.0) | (3.1) | 3.5 | (6.5) | 10.6 | (5.7) | (4.7) | (3.6) | (3.0) | (2.8) | (2.3) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.